CD4 and rheumatoid arthritis: Treatment with anti-CD3/CD28-activated CD4+ T cells can also boost Th17 polarization of PBMCs that were treated with RA synovial fluid from healthy donors, which may be due to an increase of the IL-6 and IL-1β produced by monocytes (31).